DIABETES ASIA 2009 CONFERENCE

Transcription

1 FINAL ANNOUNCEMENT 8th Continuing Professional Development (CPD) Series: DIABETES ASIA 2009 CONFERENCE October 7 11, 2009 Kuala Lumpur, Malaysia Conference Venue: Sunway Resort Hotel & SPA Convention Centre Bandar Sunway, Petaling Jaya Selangor Darul Ehsan, Malaysia Organised By: Endorsed By:

2 NADI s Continuing Professional Development Series The 8 th Continuing Professional Development (CPD) Series Diabetes Asia 2009 Conference shall have three tracks: Young Investigator Award Track 1: Practical Diabetes Care First Price: Laptop Computer (worth RM3000*) Second Price: Digital Camcorder (worth RM2000*) Track 2: Recent Advances in Diabetology Third Price: Smart Phone (worth RM1000*) *Approximate Value Track 3: Free Paper Presentation Objectives of the Conference The Continuing Professional Development (CPD) Series as Diabetes Asia 2009 Conference aims to help improve management of diabetes with emphasis on up-to-date and practical aspects of diabetes care. Participants are expected to be able to: appreciate recent advances and the practical aspects of diabetes care. understand ways of ensuring early diagnosis and optimal management for good control of diabetes, complications and associated diseases apply knowledge gained during the Conference to further improve care for persons with diabetes in the community Who Should Attend Healthcare professionals responsible for managing people with diabetes including: Medical and Surgical Specialists General Practitioners Medical and Health Officers Trainee Lecturers Pharmacists Nursing Practitioners Diabetes Educators A Certificate of Award will also be presented to the winners. The judges decision is final. No further correspondence is allowed Certificate of attendance for all Delegates and CME points are available for Malaysian Doctors, Nurses and Pharmacists The Conference will emphasise on recent advances and current practical management of diabetes, its complications and related diseases.

3 Organising Committee Patron Tun Dr. Mahathir Mohamad Advisors Tan Sri Dato Dr. Abu Bakar Suleiman Emeritus Professor Dato Khalid Abdul Kadir Professor Dato Anuar Zaini Md Zain Sub Committees Scientific Professor Dato Mafauzy Mohamed (Chairman) Professor Dato Wan Mohamad Wan Bebakar Professor Nor Azmi Kamaruddin Professor Rokiah Pendek Dr. Zanariah Hussein Dr. Malik Mumtaz Fund Raising & Exhibition Ms. Yasmin Rahimi Chairman Emeritus Professor Dato Mustaffa Embong Secretary Dato Dr. Nor Aini Abu Bakar Treasurer Ms. Rosmawati Yusoff Audiovisual Mr. Zamri Husin Social Programmes Ms. Azizah Mohd Noor Special Functions S/N Kee Poh Siew Events Coordinator Ms. Alamiah Zakaria Secretariat Ms. Nur Aliza Mustapa Conference Speakers* International Faculty: 1. Emeritus Professor Augusta D. Litonjua, Philippines 6. Professor Nigishi Hotta, Japan Professor Abdul Basit, Pakistan. Professor David Owens, CBE, United Kingdom Professor Oliver Schnell, Germany Professor Russel Scott, New Zealand 4. Professor Eberhard Standl, Germany 9. Professor Timothy Davis, Australia 5. Professor John Marthin Frederik Adam, Indonesia 10. Dr. Daphne Khoo Hsu Chin, Singapore 11. Dr. R. K. Chittoria, India Local Faculty Emeritus Professor Dato Khalid Abdul Kadir, MUM Emeritus Professor Dato Mustaffa Embong, USM Assoc. Professor Norlaila Mustafa, HUKM Dato Dr. Khoo Kah Lin, NHF Professor Puan Sri Datin Nafisah Adeeb, HUKM Professor Dato Anuar Zaini Md Zain, MUM Dato Dr. Rosli Mohd Ali, IJN Datin Dr. Liew Yin Mei, NHF 5. Professor Dato Khalid Yusoff, UiTM 27. Dr. Allan Yee Kim Chye, MDA 6. Professor Dato Mafauzy Mohamed, USM 28. Dr. David Quek Kwang Leng, DQSHC 7. Professor Dato N. Sivalingam, IMU 29. Dr. Faridah Ismail, GIMC 8. Professor Dato Wan Mohamad Wan Bebakar, USM 30. Dr. G. R. Letchuman, MOH 9. Professor Dato Zaki Morad Mohamad Zaher, IMU 31. Dr. Hew Fen Lee, SJMC 10. Professor Datin Norella Kong, HUKM 32. Dr. Lim Soo San, UM Professor Abd Rashid Abd Rahman, CUCMS Professor Amir Sharifuddin Mohd Khir, PMC Dr. Malik Mumtaz, PMC Dr. Muhammad Yazid Jalaludin, UM 13. Professor Che Muhaya Hj. Muhamad, PCMC 35. Dr. Nor Azizah Aziz, MOH Professor Fatimah Harun, UM Professor Jasmi Ali Yaakub, HUKM* Dr. Siti Harnida Md Isa, MUM Dr. Wong Ming, HUKM Professor Lekhraj Rampal, UPM Professor Nor Azmi Kamaruddin, HUKM Dr. Yeow Toh Peng, PMC Dr. Zanariah Hussein, MOH 18. Professor Rabindarjeet Singh, USM 40. Mr. Paul Jambunathan, MUM Professor Rahmattullah Khan Abd Wahab Khan, UPSI 41. Professor Rokiah Pendek, UM 42. Ms. Lee Yee Lan, MPS Ms. Mary Easaw-John, IJN Professor Syed Mohamed Aljunid Syed Junid, UKM Professor Wu Loo Ling, HUKM Ms. Shanaz Mawji, SJMC Ms. Tan Yoke Hwa, MOH *Subject to confirmation

4 Conference Outline* 7 Oct 2009 Wednesday 8 Oct Oct Oct Oct Thursday Friday Saturday Sunday Plenary 1 Plenary 5 Plenary 7 Plenary 11 Plenary 2 Plenary 6 Plenary 8 Plenary 12 Break ( ) Break ( ) Break ( ) Break ( ) ( ) ( ) ( ) ( ) 1A 1B 2A 2B 5A 5B 7A 7B ( ) Lunch Debate I ( ) Lunch Debate II ( ) Lunch 1A ( ) Lunch 2 Lunch 1B ( ) Experts Case Discussion ( ) ( ) ( ) ( ) Registration Free Paper Presentation 3A 3B 6A 6B 8A 8B Break ( ) Break ( ) Break ( ) Break ( ) ( ) Plenary 3 ( ) ( ) Plenary 9 Plenary 4 4A 4B Plenary 10 CLOSE *Subject to change Scientific Programme* Plenary 1 : Type 2 Diabetes Implications of New Genes Discovery Speaker : Professor Abdul Basit, Pakistan Plenary 2 : Novel Strategies for Type 1 Prevention Speaker : Professor Russell Scott, New Zealand Plenary 3 : The Changing Landscape of Type 2DM Management Speaker : Emeritus Professor Augusta D. Litonjua, Philippines Plenary 4 : The Renin-Angiotensin System in Diabetes Speaker : Professor John Marthin Frederik Adam, Indonesia Plenary 5 : Recent Advances in Medical Management of Diabetic Retinopathy Speaker : Professor David Owens, CBE, United Kingdom Plenary 6 : Diabetes and Cardiovascular Disease: Strategies to Overcome the Burden Speaker : Professor Oliver Schnell, Germany Plenary 7 : HDL Dysfunction in Type 2 Diabetes Speaker : Professor Russell Scott, New Zealand Plenary 8 : The Adipocyte and Diabetes Speaker : Dr. Daphne Khoo Hsu Chin, Singapore Plenary 9 : Recent Advances in Diabetic Neuropathy: Pathogenesis and Treatment Speaker : Professor Nigishi Hotta, Japan Plenary 10 : Glycemic Control and Prevention of CVD Where are we? Speaker : Professor Eberhard Standl, Germany Plenary 11 : Metabolic Syndrome Myth or Reality? Speaker : Professor Eberhard Standl, Germany Plenary 12 : Which Insulin for Type 1?: Ideal and Practical Speaker : Professor Timothy Davis, Australia Young Investigator Award Participants are invited for Young Investigator Award which is open to those accepted for oral presentation with the following criteria: 1. Age of 35 years or less (at the time of submission) 2. researcher (> 60% contribution) of an original research for the paper to be presented 3. First author of the paper 4. Paper Presenter at the Awarding Ceremony **Please fill-in the Declaration Form.

5 1: 1A. Malaysian Palm Oil Council (MPOC) Dietary Fats: Are there Modifiable Risk Factors for Diabetes and CHD 1B. Prevention & Early Diagnosis: i) Preventing Diabetic Foot Problems in Developing Countries ii) Should Pharmacological Intervention be Used for People with IFG/IGT? iii) Metabolic Syndrome in Malaysia: Implications in Clinical Practice iv) Bio-Markers in the Risk of Diabetes v) Panel Discussion 2: 2A. Merck Serono The Legacy of Metformin i) Defining Patient Suitability to Metformin ii) Glycaemic Interventions Strategies as Disease Advances iii) Case Study: a) Defining the Treatment Strategy at Diagnosis b) Defining the Treatment Strategy as Disease Advances: The Benefits of Fixed-dose Combination 2B. Management of Co Morbidities in Diabetes: i) Management of Hypertension in Diabetics From Clinical Trials to Practice ii) Hypertriglyceridaemia: An independent Risk Factor in Diabetics? iii) The Skin & Diabetes iv) Clinical Update in Diabetic Nephropathy v) Panel Discussion 3 : 3A. GSK DM & Acute Coronary Syndrome: Current Evidence & The Way Forward Diabetes: i) Glycaemic Memory and the Value of Early Intervention ii) Tailored the Long Term Management of Type 2 Diabetes Achieving and Sustaining Glycaemic Control is the Key Acute Coronary Syndrome (ACS): i) The Role of Injectable Factor Xa in ACS Management 3B. Diabetes & Pregnancy i) Epidemiology of Gestational Diabetes in Malaysia ii) Insulin Treatment and Glucose Monitoring in Pregnant Patients with Diabetes iii) Gestational Diabetes What is the Future for the Offsprings? iv) Prenatal Counselling for DM in Pregnancy v) Panel Discussion 4 : 4A. The Pathophysiology of Diabetes: Role of i) Glucotoxicity ii) Lipotoxicity iii) Abdominal Adiposity iv) Panel Discussion 4B. Management of Type 1 Diabetes i) Is Diabetes Camping Useful? ii) Empowering Youth with Diabetes iii) Schooling for Type 1: Challenges and Solutions iv) Panel Discussion 5 : 5A. AstraZenecca Managing CV Risks Aggressively in Diabetes i) Dyslipidaemia ii) Atherosclerosis iii) Hypertension 5B. Role of Government & Allied Healthcare Team in DM Management i) Economic Burden of Diabetes in Developing Countries ii) The Role of Pharmacists in Management of Diabetes iii) Enhancing Diabetes Care in the Community iv) Treating to Target Why are we failing? v) Panel Discussion 6: 6A. Solvay Pharma Residual Vascular Risks Reduction in Diabetes 6B. Paediatric Diabetes i) Using Insulin Pump in Type 1 Diabetics ii) What Exercise for Adolescent and Children with Diabetes iii) Non-Type 1 Diabetes in Children iv) Diabetes in Youth Psycho Social Challenges v) Panel Discussion 7: 7A. Servier Diabetes and Vascular Complications A New Decade of Evidence What s the Verdict 7B. Lifestyle Modification and Motivation i) Carbohydrates - What & How Much For Diabetics ii) Physical Activity Motivating Patients to Comply iii) What Patient Should Know about DSME iv) A Dietitian's Experience In Nutrition for Diabetics v) Panel Discussion 8: 8A. Obesity & Diabetes i) Childhood Obesity and Diabetes ii) Appetite Suppressants in Obese DM Patients iii) Bariatric Surgery: A Treatment of Type 2 Diabetes? iv) The Effects of Metabolic Syndrome on the Kidneys 8B. Management of Type 2 Diabetes i) Emerging Therapies for Glucose Lowering in Type 2 ii) Hypoglycaemia Unawareness : Pathophysiology & Management iii) Modulators of Alpha & Beta Cell Function iv) Is Self-monitoring Useful in Type 2 Diabetes v) Panel Discussion v) Panel Discussion Lunch Debate I : All patients with diabetes should be on statin (unless contraindicated) with target LDL-Cholesterol less than 2.0 mmol/l Lunch Debate II : Glycaemic control in T2DM is important and HbA1c should be kept at less than 6.5% Lunch 1A : Addressing the Fundamental Challenges in T2DM- A1C, Weight and (Eli Lilly) Hypoglycaemia What s New? Lunch 1B : VLCD for Weight Reduction - Time for a Revisit (Neucor Alliance) Lunch 2 : Young Investigator Award : 1. Awarding Ceremony 2. Presentation of the Award-Winning Papers a) Third Placing b) Second Placing c) First Placing *Subject to change Free paper presentation Participants are encouraged to submit free papers for oral or poster presentation. Free paper presentation is limited only to aspects relating to the practical management of diabetes, its complications and co-morbidities. Please refer to the attached paper Call for Free Paper Abstracts for instructions. Closing date for free paper abstract submission is. Experts Case Discussion 1 : Early & Effective Management of Type 2 Diabetes Experts Case Discussion 2 : Managing Co Morbidities in People with Diabetes Experts Case Discussion 3 : Managing Labile Type 1 Diabetes

6 Registration & Fees Registration form is enclosed with this FINAL ANNOUNCEMENT. Completed form must be returned with the registration fee to the Conference Secretariat by mail or fax. Registration fee covers admission to all NADI Conference sessions and trade exhibition, Conference materials, Conference lunches and tea/coffee breaks. The fees are as follows: Overseas Delegates Malaysian Delegates Registration Early Bird Before After Delegate USD500 USD650 Registration Early Bird Before After Delegate RM850 RM950 Postgraduate Student* USD450 USD550 Paramedic / Allied Health USD450 USD550 Postgraduate Student* RM700 RM850 Paramedic / Allied Health RM700 RM850 * Official endorsement from institution is required. Please register early to enjoy Early Bird discount. Payment should be made payable to: National Diabetes Institute Accommodation Special room rates have been arranged for the Conference participants from October 7-11, 2009 at the following hotels: Sunway Lagoon Resort Hotel Sun Inns Hotel Sheraton Subang (Conference Venue) - Sun Inns Menteri Holiday Villa Subang - Tower - Sun Inns Lagoon Summit Hotel - Pyramid Tower Participants are advised to reserve their hotel accommodation early, DIRECTLY with the hotel of their choice. Please specify that you wish to book as a participant of the National Diabetes Institute Conference in order to qualify for the special rates offered. Please refer to the accompanying leaflet for details. For further information and updates regarding the conference, please contact: The Secretariat visit our website: (Attention: Ms. Aliza / Ms. Azizah / Ms. Rosmawati / Ms. Kee) National Diabetes Institute (NADI) No. 1, Jalan SS 3/50, Petaling Jaya, Selangor, MALAYSIA Tel: / Fax: [email protected] About the National Diabetes Institute (NADI) The National Diabetes Institute (NADI) is established to provide a dedicated and comprehensive service for diabetics, to prevent and control diabetes and its complications. NADI is a non profit organisation registered as a company limited by guarantee. It is managed by a Board of Trustees comprising representatives from the Malaysian Endocrine and Metabolic Society (MEMS), Malaysian Diabetes Association (PDM), Ministry of Health (MOH), Elected and Founding members. The main objectives of NADI are: to be a National Diabetes Education Resource Centre for the country to create and maintain a National Diabetes Registry to establish and run a comprehensive health facility including a National Diabetes Hospital for the management of diabetes and its complications to coordinate and conduct research in diabetes and related conditions to be the national reference as well as the national coordinating centre for diabetes in Malaysia in respect to statistics, education, management, research, policy and planning on diabetes and associated diseases NADI Office : No. 1, Jalan SS 3/50, Petaling Jaya, Selangor, MALAYSIA Tel: / Fax: [email protected] Website: